BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

Running, not enrolling

Conditions studied: Primary Hyperoxaluria Type 1

In brief

The purpose of this study is to describe the natural history and progression of patients diagnosed with PH1, and to characterize the long-term real-world safety and effectiveness of lumasiran.

Key facts

Study ID
NCT04982393
Run by
Alnylam Pharmaceuticals
People needed
207
Starts
2021-12-13
Expected to finish
2028-09-01
Last updated by the study team
2026-04-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.